My strength is that of a clinical researcher and someone who has been seeing these poor devastated glioblastoma multiforma patients for a number of years.
I have no idea what the FDA thinks, does or wants to do. It becomes kind of political perhaps at that point.
What I do know however is that with curves like this, it is very very difficult if not impossible for big Pharma or the FDA to ignore it.